Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Total Current Liabilities (2016 - 2026)

Biomerica's Total Current Liabilities history spans 16 years, with the latest figure at $1.6 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 5.34% to $1.6 million in Q1 2026 year-over-year; TTM through Feb 2026 was $1.6 million, a 5.34% decrease, with the full-year FY2025 number at $1.7 million, down 21.05% from a year prior.
  • Total Current Liabilities hit $1.6 million in Q1 2026 for Biomerica, down from $1.6 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for BMRA hit a ceiling of $6.7 million in Q1 2022 and a floor of $1.4 million in Q1 2023.
  • Historically, Total Current Liabilities has averaged $2.1 million across 5 years, with a median of $1.8 million in 2022.
  • Biggest five-year swings in Total Current Liabilities: soared 395.41% in 2022 and later plummeted 79.17% in 2023.
  • Tracing BMRA's Total Current Liabilities over 5 years: stood at $1.8 million in 2022, then increased by 3.33% to $1.8 million in 2023, then increased by 2.96% to $1.9 million in 2024, then dropped by 14.77% to $1.6 million in 2025, then dropped by 2.38% to $1.6 million in 2026.
  • Business Quant data shows Total Current Liabilities for BMRA at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.7 million in Q3 2025.